Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antibiotic therapy for exacerbation].

K Dalhoff1, H Kothe

  • 1Medizinische Klinik III, Universitätsklinikum Schleswig-Holstein - Campus Lübeck. klaus.dalhoff@uni-luebeck.de

Der Internist
|July 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2022
Same author

Challenges in conducting paediatric trials with off-patent drugs.

Contemporary clinical trials communications·2021
Same author

Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade.

Infection·2021
Same author

[Community-acquired pneumonia].

Der Pneumologe·2020
Same author

Higher chlorzoxazone clearance in obese children compared with nonobese peers.

British journal of clinical pharmacology·2018
Same author

[Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology].

Pneumologie (Stuttgart, Germany)·2018
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Bacterial infections trigger about half of acute exacerbations of chronic bronchitis (AECB). Eradicating these bacterial pathogens may extend the time patients remain infection-free.

Area of Science:

  • Respiratory Medicine
  • Infectious Diseases
  • Microbiology

Context:

  • Bacterial infections are implicated in roughly 50% of acute exacerbations of chronic bronchitis (AECB).
  • Key pathogens include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
  • A link between bacterial infection, bronchial inflammation, and exacerbations is supported by culture and molecular typing studies.

Purpose:

  • To explore the role of bacterial infections in acute exacerbations of chronic bronchitis (AECB).
  • To evaluate the established benefits of antibiotic treatment for AECB.
  • To determine if bacterial eradication can prolong the infection-free interval.

Summary:

  • Bacterial infections are a significant factor in approximately 50% of AECB cases, with specific pathogens identified.

Related Experiment Videos

  • While the benefits of antibiotic therapy for AECB are not definitively established, guidelines suggest its use in certain patient groups.
  • Evidence indicates that successful bacterial eradication can lead to a longer period without recurrent infections.

    • Impact:

    • Highlights the importance of identifying and treating bacterial infections in AECB management.
    • Informs clinical guidelines regarding the appropriate use of antimicrobial therapy in AECB.
    • Suggests a potential strategy for improving patient outcomes by prolonging infection-free intervals.